Trends in Bioprocess 4.0 and their Impact on Biomanufacturing

The biomanufacturing industry is currently undergoing a revolution in how it produces biopharmaceutical products. The driving force behind this paradigm shift is known as Bioprocess 4.0 or Industry 4.0. The approach focuses on how to apply data, predictive modeling, analytics, machine learning, artificial intelligence, automation, and technology for the digital transformation of biologics manufacturing. It’s all about using data from raw materials and bioproduction operations to optimize the process. The overall goals are to improve efficiency, lower costs, and help customers get their products to market faster.

In this GEN podcast, we’ll hear from experts at MerckMillipore on how the company is applying the principles of Bioprocess 4.0 to its own biomanufacturing strategy and operations.

[vc_btn title=”View Transcript of This Podcast” style=”custom” custom_background=”#e10e2c” custom_text=”#ffffff” shape=”square” size=”lg” align=”left” i_icon_fontawesome=”fa fa-file-pdf-o” add_icon=”true” link=”||target:%20_blank|”]


Jim Neville
Director of Technology Management – Americas

John Cyganowski
Director of Manufacturing Sciences & Technologies – Americas